| Molecular Interaction Atlas (MIA) |
|
| Indication(s) of WZ4003 |
| Disease Entry |
ICD 11 |
Status |
REF |
| Discovery agent |
N.A.
|
Investigative |
[2] |
|
|
|
WZ4003 Interacts with 2 DTT Molecule(s)
| DTT Name |
DTT ID |
UniProt ID |
Mode of Action |
REF |
|
Omphalocele kinase 1 (NUAK1)
|
TT65FL0
|
NUAK1_HUMAN
|
Inhibitor
|
[2] |
|
NUAK family SNF1-like kinase 2 (NUAK2)
|
TTHVOTQ
|
NUAK2_HUMAN
|
Inhibitor
|
[2] |
| ------------------------------------------------------------------------------------ |
|
|
|
|
|
|
WZ4003 Interacts with 1 DOT Molecule(s)
| DOT Name |
DOT ID |
UniProt ID |
Mode of Action |
REF |
|
NUAK family SNF1-like kinase 1 (NUAK1)
|
OTLLHJJQ
|
NUAK1_HUMAN
|
Decreases Response To Substance
|
[2] |
| ------------------------------------------------------------------------------------ |
|
|
|
|
|
| Indication(s) of Idarubicin |
| Disease Entry |
ICD 11 |
Status |
REF |
| Acute myelogenous leukaemia |
2A41
|
Approved |
[3] |
| Acute myeloid leukaemia |
2A60
|
Approved |
[4] |
| Adult acute monocytic leukemia |
N.A.
|
Approved |
[3] |
| Childhood acute megakaryoblastic leukemia |
N.A.
|
Approved |
[3] |
| Leukemia |
N.A.
|
Approved |
[3] |
|
|
|
Idarubicin Interacts with 1 DTT Molecule(s)
| DTT Name |
DTT ID |
UniProt ID |
Mode of Action |
REF |
|
DNA topoisomerase II (TOP2)
|
TT0IHXV
|
TOP2A_HUMAN; TOP2B_HUMAN
|
Modulator
|
[6] |
| ------------------------------------------------------------------------------------ |
|
|
|
|
|
|
Idarubicin Interacts with 3 DTP Molecule(s)
| DTP Name |
DTP ID |
UniProt ID |
Mode of Action |
REF |
|
Multidrug resistance-associated protein 1 (ABCC1)
|
DTSYQGK
|
MRP1_HUMAN
|
Substrate
|
[7] |
|
P-glycoprotein 1 (ABCB1)
|
DTUGYRD
|
MDR1_HUMAN
|
Substrate
|
[8] |
|
Breast cancer resistance protein (ABCG2)
|
DTI7UX6
|
ABCG2_HUMAN
|
Substrate
|
[8] |
| ------------------------------------------------------------------------------------ |
|
|
|
|
|
|
Idarubicin Interacts with 2 DME Molecule(s)
| DME Name |
DME ID |
UniProt ID |
Mode of Action |
REF |
|
Cytochrome P450 2D6 (CYP2D6)
|
DECB0K3
|
CP2D6_HUMAN
|
Metabolism
|
[9] |
|
Cytochrome P450 2C9 (CYP2C9)
|
DE5IED8
|
CP2C9_HUMAN
|
Metabolism
|
[9] |
| ------------------------------------------------------------------------------------ |
|
|
|
|
|
|
Idarubicin Interacts with 2 DOT Molecule(s)
| DOT Name |
DOT ID |
UniProt ID |
Mode of Action |
REF |
|
Natriuretic peptides B (NPPB)
|
OTSN2IPY
|
ANFB_HUMAN
|
Increases Expression
|
[10] |
|
Bile acid receptor (NR1H4)
|
OTWZLPTB
|
NR1H4_HUMAN
|
Decreases Activity
|
[5] |
| ------------------------------------------------------------------------------------ |
|
|
|
|
|
|
|
|
|
|
|
|